Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

CoreAge Rx vs ARSYNL Rx

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, ARSYNL Rx a 67. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

CoreAge Rx

#1 · Grade A+ · Best Value

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full CoreAge Rx review →
VS

ARSYNL Rx

#290 · Grade C · Watch List

Est. first month

From $233/mo (compounded)

Save ~83% vs brand-name
Get this deal Full ARSYNL Rx review →

The verdict

Better value: CoreAge Rx

CoreAge Rx takes it on Value Score, 93 to 67 an est. $149/mo first month, with no teaser step-up baked in. ARSYNL Rx isn't out of it: Shoppers who want compounded semaglutide & tirzepatide (incl. a tirzepatide hypospray) from a veteran-founded telehealth.

CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxARSYNL Rx
Value Score93 (A+)67 (C)
Est. first month$149/moFrom $233/mo (compounded)
Save vs brand-name~89%~83%
Semaglutide$149/moFrom $233/mo (compounded)
Tirzepatide$349/moFrom $366/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
65
CoreAge Rx: 88. ARSYNL Rx: 65.
98
No Teaser-Rate Bait
72
CoreAge Rx: 98. ARSYNL Rx: 72.
98
Nationwide Availability
45
CoreAge Rx: 98. ARSYNL Rx: 45.
95
Both Molecules
92
CoreAge Rx: 95. ARSYNL Rx: 92.
95
Easy Cancellation
58
CoreAge Rx: 95. ARSYNL Rx: 58.
84
Reputation
65
CoreAge Rx: 84. ARSYNL Rx: 65.

CoreAge Rx

The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.

Why it's a deal

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation — no lock-in

The fine print

  • Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

ARSYNL Rx

ARSYNL Rx is a veteran-founded multi-service telehealth platform offering compounded GLP-1 weight-loss treatment — compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray —…

Why it's a deal

  • Offers compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray option
  • Veteran-founded telehealth with clinician-prescribed, personalized treatment
  • Multi-service platform — also covers hair restoration, TRT, sexual health, and longevity
  • Medications shipped discreetly to your home

The fine print

  • Pricing is not shown until you select a product (product pages sit behind a bot-verification gate)
  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and exact state coverage are not disclosed on the site
  • No LegitScript certification visible on the accessible pages
Get the CoreAge Rx deal Get the ARSYNL Rx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to ARSYNL Rx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.